AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Eon rockets past $1 billion valuation in under a year, raising tens of millions more
2
Monday.com founders: “We have everything needed to get to $10 billion in revenue”
3
Israel’s next tech boom: Pioneering the future of global defensetech
4
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
5
Israel ranks fourth globally for top universities per capita
More news

FIMI

12 stories about FIMI
ועידת התחזיות 2023 לילך אשר טופילסקי שותפה בכירה בקרן פימי מנכ"לית בנק דיסקונט לשעבר וידאו

“FIMI will invest in a significant high-tech company in the coming year”

29.12.22|Irad Atzmon Schmayer
Lilach Asher-Topilsky, a Senior Partner at FIMI Opportunity Funds and former CEO of Israel Discount Bank, added that the fund has one billion dollars waiting to be invested
גילון בק יור ריווליס ו שותף בכיר ב קרן פימי

FIMI acquiring Gal-Shvav for $100 million

20.05.21|Golan Hazani
Gal-Shvav focuses on mechanics, optics, motion control, production, and assembly of complex and technologically advanced systems
לילך אשר טופילסקי מנכלית בנק דיסקונט

FIMI Raises Seventh Fund, Targets $1.2 Billion

09.02.20|Golan Hazani
The Israel-based private equity firm currently has $5.5 billion in assets under management. FIMI’s sixth fund was the firm’s largest to date at $950 million
עמיר לונדון מנכ"ל קמהדע

FIMI Makes $25 Million Private Placement in Biomed Company Kamada

22.01.20|Tzally Greenberg
Israel-based private equity fund FIMI became the largest shareholder in Nasdaq and Tel Aviv-listed Kamada in November
יו"ר תאגיד טמסק לים בון הנג

Temasek in Talks for Irrigation Company Rivulis

15.01.20|Golan Hazani
Calcalist first reported in August that controlling shareholder FIMI was looking to sell Rivulis and that it had hired Goldman Sachs to do so
עובדים ב מפעל של קמהדע

FIMI Becomes Biggest Shareholder in Biomed Company Kamada

24.11.19|Golan Hazani and Tzally Greenberg
Nasdaq and Tel Aviv-listed Kamada develops protein-based pharmaceuticals for genetic disorders, as well as rabies antibodies and a serum against snake bites
מפעל עמיעד מערכות סינון בעמ קיבוץ עמיעד

FIMI in Talks to Buy Controlling Stake in Kibbutz-Owned Water Treatment Company

02.09.19|Golan Hazani
FIMI already holds 18% of London-listed Amiad Water Systems; now, it is looking to acquire up to 27% more, according to two people familiar with the matter
ועידת התעשייה של ישראל ישי דוידי מייסד ומנכ"ל קרן פימי

FIMI Moves Ahead with Acquisition of Controlling Stake in Infrastructure Company Tahal

21.08.19|Golan Hazani
Tahal performs sustainable infrastructure development projects for the water, wastewater, agriculture, solid waste, and natural gas industries, mainly in developing countries
טפטפות של חברת ריווליס

FIMI in Early Talks to Sell Irrigation Company Rivulis

20.08.19|Golan Hazani
FIMI is looking to sell Rivulis at an EBITDA multiple of 14, meaning between $500 million and $550 million, according to two people familiar with the matter
קרית שמונה קריית שמונה

Teva Completes $47.5 Million Sale of Northern Israeli Plant to Private Equity Fund FIMI

02.05.19|Hezi Sternlicht
Teva is selling the plant following its 2017 plan to ameliorate its crippling debt by divesting non-core businesses and closing or selling many of its manufacturing plants
מפעל טבע קריית שמונה

Teva to Sell Northern Israeli Facility to Private Equity Fund FIMI

06.02.19|Tzally Greenberg
Teva unveiled a reorganization plan in December 2017 to ameliorate its debilitating debt, announcing its intention to close or sale facilities and layoff 25% of employees by 2019
גילון בק יור ריווליס ו שותף בכיר ב קרן פימי

FIMI Opportunity Funds Forks Over $40 Million for 50% of BIRD Aerosystems

10.07.18|Golan Hazani
Israel-based BIRD Aerosystems is a manufacturer of airborne missile protection and surveillance systems